RxDoctor Payments Data

Anjum Owaisi, MD

Infectious Disease · Bolingbrook, ILNPI 1942341409

Payments from drug & device makers

$51in general payments, 2019–2025

Across 2 payments — averaging $25.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$32
  • Baxter Healthcare$19

What the payments were for

  • Food & beverage$51100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead1$32
Baxter Healthcare1$19

How this compares

$51 in reported general payments places this provider in the 30th percentile of 368 infectious disease providers in Illinois.

See all infectious disease providers in Illinois

Medicare billing

Part B allowed, 2024
$2,277,319
Medicare patients
477
Services billed
82,391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil14$307

Paid to pharmacies, not to this prescriber.

Other infectious disease in Bolingbrook

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →